Prognostic Impact of Body Mass index in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: An Updated Systematic Review and Meta-Analysis

Introduction Body mass index (BMI) is a common clinical parameter associated with cancer prognosis, but its association with survival outcomes in lung cancer patients receiving immune checkpoint inhibitors (ICIs) remains unclear. This study aimed to clarify the prognostic value of BMI in ICI-treated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zhe Wang MS, Mengxue Yang MS, Yanlin Zhao MS, Jiaxin Wang PhD, Mingyang Tao MS, Jingjing Yang MS, Jingxian Mao PhD, Huaijuan Guo PhD, Guohui Zhu MS, Xuebing Yan PhD
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publishing 2025-11-01
Serie:Technology in Cancer Research & Treatment
Accesso online:https://doi.org/10.1177/15330338251394573
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi